Aurinia Pharmaceuticals Inc. (AUPH) has 83 open-market insider trades by 21 insiders since 2021. Over the last six months insiders net bought $11.9M. The most active filer is Michael Robert Martin.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Kevin Tang | CEO10% Owner | — | 5 | $65.9M | 2026-06-02 |
| Neil Solomons | — | — | 7 | $13.4M | 2022-03-02 |
| Michael Robert Martin | — | — | 12 | $13.1M | 2023-03-02 |
| Peter Greenleaf | CEO | — | 5 | $6.5M | 2026-03-02 |
| Robert Bindert Huizinga | VP | — | 5 | $5.5M | 2022-03-02 |
| Stephen P. Robertson | CLO | — | 7 | $2.8M | 2026-09-10 |
| Joseph M. Miller | CFO | — | 6 | $2.1M | 2026-03-02 |
| Matthew Maxwell Donley | COO | — | 5 | $2.1M | 2026-03-02 |
| Joseph P. Hagan | Dir | — | 2 | $892K | 2023-05-19 |
| Scott Michael Habig | CCO | — | 4 | $592K | 2024-08-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Stephen P. Robertson | CLO | Sell | $190K | 2026-09-10 |
| Stephen P. Robertson | CLO | Sell | $356K | 2026-08-21 |
| Kevin Tang | CEO & 10% Owner | Buy | $12.5M | 2026-05-29 |
| Kevin Tang | Director | Buy | $12.7M | 2026-02-27 |
| Kevin Tang | Director | Buy | $13.6M | 2025-08-01 |
| Greg Keenan | — | Sell | $210K | 2025-08-01 |
Companies that share insiders with AUPH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Greg Keenan | — | Sell | $137K | 2025-03-07 |
| Matthew Maxwell Donley | COO | Sell | $1.5M | 2025-03-03 |
| Peter Greenleaf | CEO | Sell | $4.2M | 2025-03-03 |
| Greg Keenan | — | Sell | $98K | 2025-03-03 |
| Stephen P. Robertson | CLO & VP | Sell | $1.4M | 2025-03-03 |
| Joseph M. Miller | CFO | Sell | $1.4M | 2025-03-03 |
| Kevin Tang | Director | Buy | $16.3M | 2025-02-28 |
| Kevin Tang | Director | Buy | $10.8M | 2024-12-05 |
| Karen L. Smith | Director | Sell | $44K | 2024-11-11 |